Skip to content

Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures

Universal Biospecimen Collection Protocol for Extra Material From Clinical Pulmonary Procedures

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07218939
Enrollment
12000
Registered
2025-10-21
Start date
2025-10-08
Completion date
2032-12-01
Last updated
2026-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary

Brief summary

The goal of this study is to develop a biospecimen collection protocol for unused biospecimens from pulmonary procedures in order to facilitate research across many different areas of pulmonary medicine and mitigate the pulmonary morbidity experienced by patients with cancer.

Detailed description

Primary objectives: To assemble a tissue/blood bank biorepository for laboratory translational research by collecting extra samples of bronchoalveolar lavage, pleural fluid, blood or other residual tissue obtained during normally scheduled clinical procedures for the evaluation of pulmonary toxicity To collect basic data on patient data and suspected pulmonary toxicity to cross-reference eligible biospecimens

Interventions

None listed

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

All patients over the age of 18, who are seen in the Cardiopulmonary Center and are undergoing pulmonary procedures

Exclusion criteria

Pregnant women and prisoners

Design outcomes

Primary

MeasureTime frameDescription
Safety and Adverse Events (AEs)Through study completion; an average of 1 yearIncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0

Countries

United States

Contacts

CONTACTAjay Sheshadri, MD
asheshadri@mdanderson.org(713) 563-1987
PRINCIPAL_INVESTIGATORAjay Sheshadri, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 20, 2026